col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


154 Results       Page 1

 [1] 
Elsevier: European Journal of Internal Medicine
  original article Date Title Authors   All Authors
1 [GO] 2022―May―12 Treatment strategies of Covid-19. A rheumatology perspective. Alexandros A. Drosos, Eleftherios Pelechas, Paraskevi V. Voulgari
2 [GO] 2022―Apr―25 Interleukin 6 inhibition in severe COVID-19: another piece of the puzzle Nicola Farina, Lorenzo Dagna
3 [GO] 2022―Apr―22 Effects of Non-Invasive Respiratory Supports on inspiratory effort in moderate-severe COVID-19 patients. A randomized physiological study. Gioacchino Schifino, Maria L Vega, Lara Pisani, Irene Prediletto, Vito Catalanotti, Vittoria Comellini, et al. (+4)
4 [GO] 2022―Apr―14 Experience with procalcitonin use during the COVID-19 pandemic Laura Gonzalez, Thomas Holman, Daniel Waite, Pearl Abenojar
5 [GO] 2022―Apr―13 Anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with COVID-19 Rosaria Sofia, Mattias Carbone, Giovanni Landoni, Alberto Zangrillo, Lorenzo Dagna
6 [GO] 2022―Apr―07 Interleukin-6 inhibitors reduce mortality in coronavirus disease-2019: An individual patient data meta-analysis from randomized controlled trials Panagiotis T. Tasoudis, Christina K. Arvaniti, Anastasia T. Adamou, Ioannis Belios, John H. Stone, Nora Horick, et al. (+3)
7 [GO] 2022―Mar―16 The role of heparin in reducing in-hospital complications and three-month mortality rates in hospitalized COVID-19 patients F. Calabretta, P.S. Preti, M. Russo, C. Klersy, A. Di Sabatino
8 [GO] 2022―Mar―14 Physical decline and cognitive impairment in frail hypertensive elders during COVID-19 Pasquale Mone, Antonella Pansini, Salvatore Frullone, Antonio de Donato, Veronica Buonincontri, Paolo De Blasiis, et al. (+4)
9 [GO] 2022―Mar―14 Doubtful clinical benefit of casirivimab-imdevimab treatment for disease severity outcome of high-risk patients with SARS-CoV-2 delta variant infection Noah Shopen, Michal Dekel, Michal Mizrahi, Efrat Zandberg, Daniel Talmud, Neta Cohen
10 [GO] 2022―Mar―11 The Precautionary Principle in the COVID-19 vaccination campaign: the complicated relationship between the scientific community, medicines regulatory agencies and citizens Lobello Paola Aurora, Squizzato Alessandro, Picozzi Mario
11 [GO] 2022―Mar―09 “Thrombotic events following Covid-19 vaccines compared to Influenza vaccines.” Marcelo Gabriel Vallone, Andre Luis Falcón, Horacio Matias Castro, Augusto Ferraris, Ramiro Francisco Cantarella, María Inés Staneloni, et al. (+5)
12 [GO] 2022―Feb―14 Double-gloving in an Intensive Care Unit during the COVID-19 pandemic Ori Galante, Abraham Borer, Yaniv Almog, Lior Fuchs, Lisa Saidel-Odes
13 [GO] 2022―Feb―14 Is the number of long-term post-COVID symptoms relevant in hospitalized COVID-19 survivors? César Fernández-de-las-Peñas, Umut Varol, Stella Fuensalida-Novo, Susana Plaza-Canteli, Juan Antonio Valera-Calero
14 [GO] 2022―Feb―14 Reduced COVID-19 mortality linked with early antibodies against SARS-CoV-2, irrespective of age Danila De Vito, Agostino Di Ciaula, Vincenzo O. Palmieri, Paolo Trerotoli, Angela Maria Vittoria Larocca, Maria Teresa Montagna, Piero Portincasa
15 [GO] 2022―Feb―03 Acute coronary syndromes during the first and the second wave of COVID-19 Marco Ferlini, Diego Castini, Luigi Oltrona Visconti, Stefano Carugo
16 [GO] 2022―Jan―31 Usefulness of non-invasive methods for the monitoring of oxygenation parameters in patients with COVID-19 associated ARDS Diego Alberto Pérez Pinzón, Cristin Camilo Villa Gómez, Julio Andrés Boada Garnica, Marlon Adrián Laguado Nieto
17 [GO] 2022―Jan―28 Pulmonary embolism severity and in-hospital mortality: An international comparative study between COVID-19 and non-COVID patients Òscar Miró, Sònia Jiménez, Pere Llorens, Melanie Roussel, Judith Gorlicki, Eric Jorge García-Lamberechts, et al. (+10)
18 [GO] 2022―Jan―24 T-cell response to 3 doses of Sars-Cov2 BNT162b2 Pfizer vaccine in long term rituximab treated patients Jade Heitz, Jerome Razanamahery, Sylvain Audia, Jean-Baptiste Bour, Julien Guy, Sabine Berthier, et al. (+5)
19 [GO] 2022―Jan―21 Efficacy and safety of therapeutic vs. prophylactic bemiparin in noncritically ill patients with COVID-19 pneumonia. Jose F Varona, Elena Núñez, Borja M. Fernández Félix, Jose María Castellano Vázquez, Antonio Cubillo
20 [GO] 2022―Jan―12 COVID-19 Infection Survivors and the Risk of Depression and Anxiety Symptoms: A Nationwide Study of Adults in the United States Jagdish Khubchandani, James H. Price, Sushil Sharma, Fern J. Webb
21 [GO] 2022―Jan―10 Return to work after hospitalisation for COVID-19 infection Orlando Hürlimann, Pierre Decavel, Jean-Marie Annoni, Marco Mancinetti
22 [GO] 2022―Jan―07 Convalescent plasma for COVID-19. TSUNAMI is not the final word Massimo Franchini, Daniele Focosi, Arturo Casadevall, Michael J. Joyner, Cesare Perotti
23 [GO] 2022―Jan―05 SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure Jesús Fernando García-Cruces-Méndez, Luis Corral-Gudino, María Piedad Del-Amo-Merino, José María Eiros-Bouza, Marta Domínguez-Gil González
24 [GO] 2021―Dec―21 CORRELATION OF NON-INVASIVE OXYGENATION PARAMETERS WITH paO2/FiO2 RATIO IN PATIENTS WITH COVID-19 ASSOCIATED ARDS Giacomo Zaccagnini, Andrea Berni, Filippo Pieralli
25 [GO] 2021―Dec―21 The relevance of nutritional and metabolic derangements in COVID-19 patients Alessio Molfino, Giovanni Imbimbo, Maurizio Muscaritoli
26 [GO] 2021―Dec―07 Factors associated with persistence of symptoms 1 year after COVID-19: a longitudinal, prospective phone-based interview follow-up cohort study Carlo Fumagalli, Chiara Zocchi, Luigi Tassetti, Maria Vittoria Silverii, Carla Amato, Luca Livi, et al. (+11)
27 [GO] 2021―Nov―29 Short term Blood Pressure Alterations in Recently COVID-19 Vaccinated Patients Elias Sanidas, Theoharis Anastasiou, Dimitrios Papadopoulos, Maria Velliou, Marina Mantzourani
28 [GO] 2021―Nov―25 Colchicine for the prevention of COVID-19 “hard” outcomes: all that glitters is not gold Dimitrios Patoulias, Christodoulos Papadopoulos, Asterios Karagiannis, Michael Doumas
29 [GO] 2021―Nov―22 Tocilizumab in severe COVID-19: A promise fulfilled Marcel Levi
30 [GO] 2021―Nov―13 Colchicine for COVID-19: hype or hope? Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
31 [GO] 2021―Nov―12 Learning in times of stress: lessons from COVID-19 that will last throughout this century. Paula Jiménez-Fonseca, Ramón Salazar, Vicent Valentí, Alberto Carmona-Bayonas, Giancarlo Agnelli
32 [GO] 2021―Nov―11 Anakinra in COVID-19: A step closer to the cure Fotios Barkas, Eirini Christaki, Evangelos Liberopoulos, Maria Kosmidou, Haralampos Milionis
33 [GO] 2021―Nov―11 Anticoagulant therapy for COVID-19: What we have learned and what are the unanswered questions? Dimitrios Giannis, James D. Douketis, Alex C. Spyropoulos
34 [GO] 2021―Oct―27 Hydroxichloroquine for COVID-19 infection: do we have a final word after one year? Dr. Augusto Di Castelnuovo, Simona Costanzo, Alessandro Gialluisi, Licia Iacoviello, Giovanni de Gaetano
35 [GO] 2021―Oct―27 Humoral SARS-COV-2 IgG decay within 6 months in COVID-19 healthy vaccinees: The need for a booster vaccine dose? Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, Gil Harari, Michael Gurevich
36 [GO] 2021―Oct―25 One year later: The case of tocilizumab in COVID-19 Corrado Campochiaro, Alessandro Tomelleri, Marco Matucci-Cerinic, Lorenzo Dagna
37 [GO] 2021―Oct―25 Standardized PaO2/FiO2 ratio in COVID-19: added Added value or risky assumption. Author's reply Irene Prediletto, Stefano Nava, Paolo Palange
38 [GO] 2021―Oct―25 Predicting adverse outcomes in patients with COVID-19: just an epidemiological debate or a valuable clinical approach? Xavier Corbella
39 [GO] 2021―Oct―22 Serum IgG4 elevation in hyper-inflamed COVID-19 patients. Author's reply Emanuel Della-Torre, Marco Lanzillotta, Giuseppe Alvise Ramirez, Lorenzo Dagna, Moreno Tresoldi
40 [GO] 2021―Oct―19 COVID-19 vaccination and a severe pain in the neck Angelos Kyriacou, Stamatina Ioakim, Akheel A. Syed
41 [GO] 2021―Oct―15 Electrocardiographic Features of Patients with COVID-19: One Year of Unexpected Manifestations Fabio Angeli, Gianpaolo Reboldi, Antonio Spanevello, Roberto De Ponti, Dina Visca, Jacopo Marazzato, et al. (+5)
42 [GO] 2021―Oct―12 Cardiopulmonary exercise test with stress echocardiography in COVID-19 survivors at 6 months follow-up Luca Vannini, Alejandro Quijada-Fumero, M Purificación Ramirez Martín, Nuria Castejón Pina, Julio S. Hernandez Afonso
43 [GO] 2021―Sep―24 Serum IgG4 level predicts COVID-19 related mortality Emanuel Della-Torre, Marco Lanzillotta, Marta Strollo, Giuseppe Alvise Ramirez, Lorenzo Dagna, Moreno Tresoldi
44 [GO] 2021―Sep―23 The coupling between sarcopenia and COVID-19 is the real problem Rizwan Qaisar, Asima Karim, Tahir Muhammad, Islam Shah, M. Shahid Iqbal
45 [GO] 2021―Sep―20 The Pivotal Link Between ACE2 Deficiency and SARS-CoV-2 Infection: One Year Later Fabio Angeli, Martina Zappa, Gianpaolo Reboldi, Monica Trapasso, Claudio Cavallini, Antonio Spanevello, Paolo Verdecchia
46 [GO] 2021―Sep―09 Standardised PaO2/FiO2 ratio in COVID-19: added value or risky assumptions? Luciano Gattinoni, Mattia Busana, Luigi Camporota
47 [GO] 2021―Sep―09 Vitamin D deficiency and inactivated SARS-CoV-2 vaccines Chia-Chao Wu, Kuo-Cheng Lu
48 [GO] 2021―Sep―02 Long term consequences of COVID-19 Anna Berenguera
49 [GO] 2021―Aug―30 Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care. Lucia Taramasso, Laura Magnasco, Federica Portunato, Federica Briano, Antonio Vena, Daniele R. Giacobbe, et al. (+11)
50 [GO] 2021―Aug―28 EXPLORING THE POSSIBLE LINK BETWEEN MYOCARDITIS AND mRNA COVID-19 VACCINES Gianfranco Sinagra, Marco Merlo, Aldostefano Porcari
51 [GO] 2021―Aug―25 One year on: the impact of COVID-19 on clinical research Luigi Tavazzi, Aldo P Maggioni, Claudio Rapezzi, Roberto Ferrari
52 [GO] 2021―Aug―16 SARCOPENIC OBESITY IS THE REAL PROBLEM IN COVID-19 ! Murat Kara, Ayşe Merve Ata, Levent Özçakar
53 [GO] 2021―Aug―16 Examination of the relationship between emergency department presentations and population mortality: a multicenter analysis of emergency department presentations during the COVID-19 pandemic Monica Solbiati, Lorenzo Russo, Anna Beverina, Paolo Groff, Andrea Strada, Ludovico Furlan, et al. (+3)
54 [GO] 2021―Aug―16 ChAdOx1 nCoV-19 EFFECTIVENESS DURING AN UNPRECEDENTED SURGE IN SARS COV-2 INFECTIONS Ruma Satwik, Ambarish Satwik, Satendra Katoch, Satish Saluja
55 [GO] 2021―Jul―10 Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT) Jose F. Varona, Millán García-Isidro, Mojdeh Moeinvaziri, María Ramos-López, Manuel Fernández-Domínguez
56 [GO] 2021―Jul―02 The link between nutritional status and outcomes in COVID-19 patients in ICU: Is obesity or sarcopenia the real problem? Alessio Molfino, Giovanni Imbimbo, Veronica Rizzo, Maurizio Muscaritoli, Daniela Alampi
57 [GO] 2021―Jun―29 Vaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against COVID-19 pandemic: what pathogenesis? Raimondo De Cristofaro, Maurizio Sanguinetti
58 [GO] 2021―Jun―24 Laryngotracheal aspiration test reduce the false negative rate in patients with suspected SARS-COV-2 pneumonia despite a negative nasopharyngeal swab Peiman Nazerian, Roberto M. Sacco, Monica Solbiati, Elena Targetti, Chiara Marta, Francesco Blasi, et al. (+6)
59 [GO] 2021―Jun―18 Mask-off Policy in the Shadow of Emerging Variants of SARS-COV-2 Abdolrazagh Hashemi Shahraki, Majid Vahed, Mehdi Mirsaeidi
60 [GO] 2021―Jun―17 Standardizing PaO2 for PaCO2 in P/F ratio predicts in-hospital mortality in acute respiratory failure due to Covid-19: a pilot prospective study Irene Prediletto, Letizia D Antoni, Paolo Carbonara, Federico Daniele, Roberto Dongilli, Roberto Flore, et al. (+7)
61 [GO] 2021―Jun―16 Prevalence of Post-COVID-19 Symptoms in Hospitalized and Non-Hospitalized COVID-19 Survivors: A Systematic Review and Meta-Analysis César Fernández-de-las-Peñas, Domingo Palacios-Ceña, Víctor Gómez-Mayordomo, Lidiane L Florencio, María L. Cuadrado, Gustavo Plaza-Manzano, Marcos Navarro-Santana
62 [GO] 2021―Jun―16 Blood Pressure Increase After Pfizer/BioNTech SARS-CoV-2 Vaccine: Pfizer/BioNTech SARS-CoV-2 Vaccine and Blood Pressure Martina Zappa, Paolo Verdecchia, Antonio Spanevello, Dina Visca, Fabio Angeli
63 [GO] 2021―Jun―12 LUNG ULTRASOUND IN COVID-19: INSIGHTS FROM THE FRONTLINE AND RESEARCH EXPERIENCES Chiara Cogliati, Frank Bosch, Yale Tung-Chen, Nick Smallwood, Juan Torres-Macho
64 [GO] 2021―Jun―05 Anakinra or tocilizumab for prevention of COVID-19 death? A big dilemma Dimitrios Patoulias, Athina Dimosiari, Theodoros Michailidis
65 [GO] 2021―May―25 Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines Marco Cattaneo
66 [GO] 2021―May―25 SARS-CoV-2 vaccine-induced cerebral venous thrombosis Alfonso Ciccone
67 [GO] 2021―May―18 SARS-CoV-2 Antibody Kinetics Eight Months from COVID-19 Οnset: Persistence of Spike Antibodies but Loss of Neutralizing Antibodies in 24% of Convalescent Plasma Donors Evangelos Terpos, Dimitris Stellas, Margherita Rosati, Theodoros N. Sergentanis, Xintao Hu, Marianna Politou, et al. (+11)
68 [GO] 2021―May―14 Incident atrial fibrillation and its risk prediction in patients developing COVID-19:A machine learning based algorithm approachs Gregory Y.H. Lip, Ash Genaidy, George Tran, Patricia Marroquin, Cara Estes
69 [GO] 2021―Apr―30 Convalescent plasma in the management of COVID-19 pneumonia Ayman Elbadawi, Mina Shnoda, Maryrose Laguio-Vila, Mamas A. Mamas, Islam Y. Elgendy
70 [GO] 2021―Apr―30 Healthcare students: should they be prioritized for COVID-19 vaccination? Michele Augusto Riva, Maria Emilia Paladino, Michael Belingheri
71 [GO] 2021―Apr―30 SARS-CoV-2 Vaccines: Lights and Shadows Fabio Angeli, Antonio Spanevello, Gianpaolo Reboldi, Dina Visca, Paolo Verdecchia
72 [GO] 2021―Apr―20 Joint Effect of Heart Failure and Coronary Artery Disease on the Risk of Death during Hospitalization for COVID-19 Fabio Angeli, Jacopo Marazzato, Paolo Verdecchia, Antonella Balestrino, Claudio Bruschi, Piero Ceriana, et al. (+12)
73 [GO] 2021―Apr―08 Prevalence of proximal deep vein thrombosis in hospitalized COVID-19 patients Guillaume Reichert, Vincent Bunel, Dora Dreyfuss, Loukbi Saker, Antoine Khalil, Hervé Mal
74 [GO] 2021―Apr―02 nObesity as an Adipose tissue dysfunction disease and A Risk Factor for Infections - Covid-19 as a case study Landecho MF, Marin-Oto M, Recalde-Zamacona B, Bilbao I, Gema Frühbeck
75 [GO] 2021―Mar―27 Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19 George N. Dalekos, Aggelos Stefos, Sarah Georgiadou, Vasiliki Lygoura, Anastasia Michail, George Ntaios, et al. (+8)
76 [GO] 2021―Mar―27 Intermediate Dose Thromboprophylaxis in SARS-CoV-2 related Venous Thrombo Embolism Zahra Haider, Kanendran Rajalingam, Tanveer Khalid, Dilip Oswal, Akshay Dwarakanath
77 [GO] 2021―Mar―20 The power of choice: Experimental evidence that freedom to choose a vaccine against COVID-19 improves willingness to be vaccinated Philipp Sprengholz, Sarah Eitze, Lars Korn, Regina Siegers, Cornelia Betsch
78 [GO] 2021―Mar―20 Pneumothorax/pneumomediastinum in non-intubated COVID-19 patients: differences between first and second Italian pandemic wave Diego Palumbo, Corrado Campochiaro, Alessandro Belletti, Alessandro Marinosci, Lorenzo Dagna, Alberto Zangrillo, Francesco De Cobelli
79 [GO] 2021―Mar―20 Pre-admission atrial fibrillation in COVID-19 patients: prevalence and clinical impact Vincenzo Russo, Angelo Silverio, Fernando Scudiero, Pierpaolo Di Micco, Marco Di Maio
80 [GO] 2021―Mar―20 When Is It Reasonable to Extrapolate During a Pandemic?: The Case of Broad UK Labeling for AstraZeneca COVID-19 Vaccine Rafael Dal-Ré, Rita Banzi
81 [GO] 2021―Mar―14 Loneliness that destroys and upsets: a lesson from and beyond COVID-19 Christian Bracco, Remo Melchio, Elena Migliore, Chiara Marrale, Luigi Fenoglio
82 [GO] 2021―Mar―07 USEFULNESS OF STEP DOWN UNITS TO MANAGE SURVIVORS OF CRITICAL COVID-19 PATIENTS Piero Ceriana, Michele Vitacca, Mara Paneroni, Stefano Belli, Nicolino Ambrosino
83 [GO] 2021―Feb―26 DNA genotyping of the ABO gene showed a significant association of the A-group (A1/A2 variants) with severe COVID-19. Juan Gómez, Guillermo M Albaiceta, Marta García-Clemente, José M. García-Gala, Eliecer Coto
84 [GO] 2021―Feb―26 Mid-term Prognostic Implication of hospitalized COVID-19 patients with Prior Heart Failure diagnosis Pau Llàcer, Luis Manzano, Cristina Fernández, Mari Carmen Moreno, Julio Núñez
85 [GO] 2021―Feb―26 Non-invasive respiratory support in the treatment of acute hypoxemic respiratory failure secondary to CoViD-19 related pneumonia Paolo Groff, Rodolfo Ferrari
86 [GO] 2021―Feb―15 DIAGNOSIS OF INFECTION BY SARS-COV-2: IS ONE MOLECULAR TEST ENOUGH? Antonella Mencacci, Maria Cristina Vedovati, Barbara Camilloni, Elio Cenci, Cecilia Becattini
87 [GO] 2021―Feb―06 Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies. Laura Pasin, Giulio Cavalli, Paolo Navalesi, Nicolò Sella, Giovanni Landoni, Andrey G. Yavorovskiy, et al. (+4)
88 [GO] 2021―Feb―05 “Let me choose my COVID-19 vaccine” Rafael Dal-Ré, Richard Stephens, Nadarajah Sreeharan
89 [GO] 2021―Feb―05 SARS-CoV-2 seroprevalence in the Vatican City State Massimo Ralli, Andrea Arcangeli, Paolo Maurizio Soave, Cristina Voglino, Fabio De-Giorgio
90 [GO] 2021―Jan―31 Assessing the Impact of Covid-19 on the Health of Geriatric Patients: the European GeroCovid Observational Study Caterina Trevisan, Susanna Del Signore, Stefano Fumagalli, Pietro Gareri, Alba Malara, Enrico Mossello, et al. (+7)
91 [GO] 2021―Jan―22 A systematic bias assessment of top-cited full-length original clinical investigations related to COVID-19 Islam Y. Elgendy, Nayef Nimri, Amr F. Barakat, Joseph Ibrahim, John Mandrola, Andrew Foy
92 [GO] 2021―Jan―02 Lung ultrasonography: a prognostic tool in non-ICU hospitalized patients with COVID-19 pneumonia. Casella Francesco, Barchiesi Marco, Leidi Federica, Russo Giulia, Casazza Giovanni, Valerio Giulia, et al. (+6)
93 [GO] 2021―Jan―01 Flying higher than politics: the goal of preventive medicine at the time of the COVID-19 pandemic Francesco M. Galassi, Michael E. Habicht, F. Donald Pate, Elena Varotto
94 [GO] 2020―Dec―29 Low influenza vaccination coverage among hospitalized COVID-19 patients in Milan: a gap to be urgently filled. Anna Lisa Ridolfo, Laura Milazzo, Andrea Giacomelli, Letizia Oreni, Catia Borriello, Spinello Antinori
95 [GO] 2020―Dec―21 NEWS2 is a valuable tool for appropriate clinical management of COVID-19 patients Marta Rigoni, Emanuele Torri, Giandomenico Nollo, Livia Delle Donne, Susanna Cozzio
96 [GO] 2020―Nov―30 How does SARS-CoV-2 targets the elderly patients? A review on potential mechanisms increasing disease severity. Annemieke Smorenberg, Edgar JG Peters, Paul LA van Daele, Esther J Nossent, Majon Muller
97 [GO] 2020―Nov―23 Hydroxychloroquine for COVID-19: Balancing contrasting claims Peter W. Horby, Jonathan Emberson
98 [GO] 2020―Nov―12 The COVID-19 burden for health care professionals: Results of a global survey Matthias Schneider, Martin Altersberger, Christina Binder, Christian Hengstenberg, Thomas Binder
99 [GO] 2020―Nov―09 End-Stage renal disease and 30-day mortality for adults with and without COVID-19 Stephanie L. Harrison, Benjamin J.R. Buckley, Elnara Fazio-Eynullayeva, Paula Underhill, Deirdre A. Lane, Gregory Y.H. Lip
100 [GO] 2020―Nov―03 Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19 Marcello Di Nisio, Nicola Potere, Matteo Candeloro, Antonella Spacone, Leonardo Pieramati, Giovanna Ferrandu, et al. (+7)
101 [GO] 2020―Oct―31 Temporal changes in co-morbidities and mortality in patients hospitalized for COVID-19 in Italy Fabio Angeli, Tiziana Bachetti
102 [GO] 2020―Oct―28 Large-scale use of hydroxychloroquine for COVID-19 confirms safety, if not effectiveness Giulio Cavalli, Lorenzo Dagna
103 [GO] 2020―Oct―23 Venous thromboembolism and COVID-19: mind the gap between clinical epidemiology and patient management Michela Giustozzi, Maria Cristina Vedovati, Giancarlo Agnelli
104 [GO] 2020―Oct―16 Does Hydroxychloroquine Reduce Mortality for COVID-19? Silvano GALLUS, Antonio CLAVENNA, Alessandra LUGO
105 [GO] 2020―Oct―15 DISEASE COURSE IN PATIENTS WITH SYSTEMIC AUTOIMMUNE DISEASES: INSIGHTS ON THE SAFETY OF IMMUNOSUPPRESSION DURING THE SARS-COV-2 OUTBREAK IN ITALY Benfaremo Devis, Perini Lucia, Marconi Valentina, Luchetti Michele Maria, Gabrielli Armando
106 [GO] 2020―Oct―06 Significant increase in the incidence of high-risk pulmonary embolism during the COVID-19 shutdown: The pandemic response causes serious collateral consequences Paul Gressenberger, Thomas Gary, Reinhard B. Raggam, Andrea Borenich, Marianne Brodmann
107 [GO] 2020―Sep―25 Change over time of COVID-19 hospital presentation in Northern Italy Giuseppe Patti, Marco Mennuni, Francesco Della Corte, Enrico Spinoni, Pier Paolo Sainaghi
108 [GO] 2020―Sep―22 COVID-19 randomized controlled trials in medRxiv and PubMed Yuki Kataoka, Shiho Oide, Takashi Ariie, Yasushi Tsujimoto, Toshi A. Furukawa
109 [GO] 2020―Sep―17 Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis. Loris Roncon, Marco Zuin, Stefano Barco, Luca Valerio, Giovanni Zuliani, Pietro Zonzin, Stavros V Konstantinides
110 [GO] 2020―Aug―25 Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study Augusto Di Castelnuovo, Simona Costanzo, Andrea Antinori, Nausicaa Berselli, Lorenzo Blandi, Raffaele Bruno, et al. (+100)
111 [GO] 2020―Aug―13 Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: new case reports coming out Lucia De Franceschi, Enrico Costa, Francesco Dima, Matteo Morandi, Oliviero Olivieri
112 [GO] 2020―Jul―21 COVID-19 and hydroxychloroquine: Let the available data speak for themselves Ugo Paliani, Andrea Cardona
113 [GO] 2020―Jul―21 Italian Vò municipality cohort and COVID-19 epidemiology: The “Framingham” study of the 21st century Marco Zuin, Claudio Bilato, Giovanni Zuliani, Loris Roncon
114 [GO] 2020―Jul―09 Published evidence on COVID-19 in top-ranked journals: A descriptive study Juan M Pericàs, Andrea Arenas, Orla Torrallardona-Murphy, Helena Valero, David Nicolás
115 [GO] 2020―Jul―07 Romeo and Juliet: Revisited (at the time of COVID-19) Giorgio Costantino, Flora Peyvandi, Nicola Montano, Carlo Agostoni
116 [GO] 2020―Jul―07 Waste in COVID-19 clinical trials conducted in western Europe Rafael Dal-Ré, Ignacio Mahillo-Fernández
117 [GO] 2020―Jul―07 Linking hydroxychloroquine to hemolysis in a ‘suspected’ glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection - a critical appraisal T.P. Afra, Ram Vasudevan Nampoothiri, Muhammed Razmi T, N. A. Bishurul Hafi
118 [GO] 2020―Jun―28 First comes the A, then the B: what we learned from the COVID-19 outbreak Roberto Copetti, Giulia Amore, Carmine Cristiano Di Gioia, Daniele Orso
119 [GO] 2020―Jun―23 Chloroquine and COVID-19: A western medical and scientific drift? Matthieu Million, Yanis Roussel, Didier Raoult
120 [GO] 2020―Jun―20 Electrocardiographic features of patients with COVID-19 pneumonia Fabio Angeli, Antonio Spanevello, Roberto De Ponti, Dina Visca, Jacopo Marazzato, Giulia Palmiotto, et al. (+4)
121 [GO] 2020―Jun―13 No double-edged sword and no doubt about the relation between smoking and COVID-19 severity Silvano GALLUS, Alessandra LUGO, Giuseppe GORINI
122 [GO] 2020―Jun―12 Very low reporting rate of connective tissue diseases among coronavirus disease 2019 (Covid-19) patients and the renin-angiotensin system - An overlooked association? Alessandro Giollo, Giovanni Cioffi, Maurizio Rossini, Ombretta Viapiana, Giovanni De Simone
123 [GO] 2020―Jun―10 Management and outcomes of post-acute COVID-19 patients in Northern Italy Michele Vitacca, Giovanni Battista Migliori, Antonio Spanevello, Mario Giovanni Melazzini, Nicolino Ambrosino
124 [GO] 2020―Jun―09 SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy Gregorio Paolo Milani, Emanuele Montomoli, Valentina Bollati, Benedetta Albetti, Claudio Bandi, Tommaso Bellini, et al. (+34)
125 [GO] 2020―Jun―07 Need for innovative and timely synthesis of evidence during Covid-19 outbreak Giulio Francesco Romiti, Bernadette Corica, Roberto Cangemi, Stefania Basili, Valeria Raparelli
126 [GO] 2020―Jun―06 PROTECTIVE ROLE OF CHRONIC TREATMENT WITH DIRECT ORAL ANTICOAGULANTS IN ELDERLY PATIENTS AFFECTED BY INTERSTITIAL PNEUMONIA IN COVID-19 ERA Rosario Rossi, Francesca Coppi, Marisa Talarico, Giuseppe Boriani
127 [GO] 2020―Jun―05 COVID-19, a viral endocrinological disease? Tiziana Grassi, Elena Varotto, Francesco M. Galassi
128 [GO] 2020―Jun―04 COVID-19 and hydroxychloroquine: is the wonder drug failing? Ugo Paliani, Andrea Cardona
129 [GO] 2020―Jun―02 COVID-19: The Waterloo of governments, healthcare systems, and large health organizations. Michael Doumas, Konstantinos P. Imprialos, Dimitrios Patoulias, Alexandra Katsimardou, Konstantinos Stavropoulos
130 [GO] 2020―Jun―01 Hepatic consequences of COVID-19 infection. Lapping or biting? Piero Portincasa, Marcin Krawczyk, Antonia Machill, Frank Lammert, Agostino Di Ciaula
131 [GO] 2020―May―28 Active smoking and severity of coronavirus disease 2019 (COVID-19): Differences in measurement of variables could cause errors in the results. Sánchez JJ, Acevedo N, Guzmán E
132 [GO] 2020―May―28 Covid-19 in Italy: lesson from the Veneto Region Giacomo Mugnai, Claudio Bilato
133 [GO] 2020―May―28 Balancing the need for rapid and rigorous scientific data during early phase of the COVID-19 pandemic: A further role for the scientific community Mario Rotondi, Manuel Nieto-Diaz, Flavia Magri, Antonio Oliviero
134 [GO] 2020―May―28 The eighth alternative to Evidence Based Medicine in the early era of the COVID-19 pandemic: too much Emergency and Emotion, too little Evidence. Filippo Pieralli, Vieri Vannucchi, Iacopo Olivotto
135 [GO] 2020―May―28 Does active smoking worsen Covid-19? Alberto Carmona Bayonas, Paula Jimenez-Fonseca, Álvaro Sánchez Arraez, Felipe Álvarez Manceñido, Eduardo Castañón
136 [GO] 2020―May―22 Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study Corrado Campochiaro, Emanuel Della-Torre, Giulio Cavalli, Giacomo De Luca, Marco Ripa, Nicola Boffini, et al. (+10)
137 [GO] 2020―May―21 Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy Valentina Morena, Laura Milazzo, Letizia Oreni, Giovanna Bestetti, Tommaso Fossali, Cinzia Bassoli, et al. (+22)
138 [GO] 2020―May―16 Tocilizumab for severe COVID-19: a promising intervention affecting inflammation and coagulation Marcel Levi
139 [GO] 2020―May―16 Why should we use convalescent plasma for COVID-19? Massimo Franchini
140 [GO] 2020―May―15 Good times, bad times: A diary of a physician in the COVID-19 era Tommaso Lupia, Giacomo Stroffolini, Roberto Angilletta, Stefano Bonora, Giovanni Di Perri
141 [GO] 2020―May―13 Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia Ruggero Capra, Nicola De Rossi, Flavia Mattioli, Giuseppe Romanelli, Cristina Scarpazza, Maria Pia Sormani, Stefania Cossi
142 [GO] 2020―May―08 Active smoking and severity of coronavirus disease 2019 (COVID-19): the use of significance testing leads to an erroneous conclusion Ernest Lo, Benoit Lasnier
143 [GO] 2020―May―07 Bleeding in COVID-19 severe pneumonia: The other side of abnormal coagulation pattern? Clara Benedetta Conti, Sonia Henchi, Giovanni Paolo Coppeta, Sophie Testa, Roberto Grassia
144 [GO] 2020―May―03 Do we know when to end isolation of persons affected with COVID-19? Dror Dicker, Tatiana Kournos, Dana Marcoviciu, Rachel Golan
145 [GO] 2020―May―01 Active smoking and COVID-19: a double-edged sword Giuseppe Lippi, Fabian Sanchis-Gomar, Brandon Michael Henry
146 [GO] 2020―Apr―30 Covid-19 cases in a no-Covid-19 geriatric acute care setting. A sporadic occurrence? Stefano Fumagalli, Bernardo Salani, Luciano Gabbani, Enrico Mossello, Andrea Ungar
147 [GO] 2020―Apr―30 The quality of the reported sample size calculation in clinical trials on COVID-19 patients indexed in PubMed Paul H. Lee
148 [GO] 2020―Apr―23 Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data Paulo Ricardo Martins-Filho, Carolina Santos Souza Tavares, Victor Santana Santos
149 [GO] 2020―Apr―23 Smoking habit and hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related pneumonia: The unsolved paradox behind the evidence. Giovanna Garufi, Luisa Carbognin, Armando Orlandi, Giampaolo Tortora, Emilio Bria
150 [GO] 2020―Apr―23 SARS-CoV-2 detection in the pericardial fluid of a patient with cardiac tamponade Andrea Farina, Giuseppe Uccello, Marta Spreafico, Giorgio Bassanelli, Stefano Savonitto
151 [GO] 2020―Apr―20 The pivotal link between ACE2 deficiency and SARS-CoV-2 infection Paolo Verdecchia, Claudio Cavallini, Antonio Spanevello, Fabio Angeli
152 [GO] 2020―Apr―13 COVID-19: TIMING IS IMPORTANT Giovanni de Simone, Costantino Mancusi
153 [GO] 2020―Apr―08 Is low sodium intake a risk factor for severe and fatal COVID-19 infection? Adrian Post, Robin P.F. Dullaart, Stephan J.L. Bakker
154 [GO] 2020―Mar―16 Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19) Giuseppe Lippi, Brandon Michael Henry
 [1] 

154 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.005 sec